Evidence map›Paper›PMID 41805575›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Mixed-mobility supported lipid bilayers uncover the role of immobilized ICAM1 on T cell activation and immune synapse organization.

Alexander Leithner, Audun Kvalvaag, Tanmay Mitra, Salvatore Valvo, Hannah Dada, Ewoud Compeer, Michael I Barton, Sofia Bustamante Eguiguren, Edward Jenkins, Christoffer Lagerholm and 2 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Alexander LeithnerThe Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford OX3 7FY, United Kingdom.ORCID 0000-0002-1073-744X
Audun Kvalvaag *Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo 0379, Norway.
Tanmay Mitra *The Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford OX3 7FY, United Kingdom.
Salvatore Valvo *The Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford OX3 7FY, United Kingdom.
Hannah DadaThe Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford OX3 7FY, United Kingdom.
Ewoud CompeerThe Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford OX3 7FY, United Kingdom.
Michael I BartonSir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom.
Sofia Bustamante EguigurenSir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom.
Edward JenkinsThe Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford OX3 7FY, United Kingdom.
Christoffer LagerholmThe Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford OX3 7FY, United Kingdom.
Omer DushekSir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom.ORCID 0000-0001-5847-5226
Michael L DustinThe Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford OX3 7FY, United Kingdom.ORCID 0000-0003-4983-6389

Funding

Austrian Science Fund (FWF) J4542-BChinese Academy of Medical Sciences (CAMS) 2018-I2M-2-002CSRD VA 1UKRI | Biotechnology and Biological Sciences Research Council (BBSRC) BB/X015408/1
6 · The paper itself

Abstract

The immunological synapse (IS) integrates antigen recognition and adhesion to control T cell activation and effector functions. Reductionist systems have been instrumental in dissecting IS organization, but conventional systems constrain all ligands to be either mobile or immobile, unlike antigen-presenting cells where intercellular adhesion molecule 1 (ICAM1) is cytoskeletally anchored while T cell receptor (TCR) ligands remain mobile. Here, we establish mixed-mobility supported lipid bilayers (SLBs) that simultaneously present mobile TCR agonists and immobile ICAM1. Selective immobilization of ICAM1 disrupts centripetal F-actin flow, prevents centralization of TCR microclusters and shifts signaling to peripheral microclusters. This attenuates TCR downregulation through ectocytosis while maintaining recycling, and enhances integrin mechanotransduction, reflected in increased phosphorylation of Focal Adhesion Kinase, Paxillin, and the stretch-sensitive adaptor CasL. Functionally, immobilized ICAM1 augments T cell activation, degranulation, Perforin release, and cytotoxicity. Importantly, these findings were recapitulated in a cell-cell system engineered to express either full-length, cytoskeleton-anchored ICAM1 or a truncated form lacking cytoskeletal association, with full-length ICAM1 consistently promoting stronger effector responses. These findings identify ligand mobility as a key biophysical parameter that shapes IS organization and T cell effector responses and establish mixed-mobility SLBs as a powerful tool for probing receptor mechanics in immunity.

Indexed as

CD8-Positive T-LymphocytesIntercellular Adhesion Molecule-1Lipid BilayersLymphocyte ActivationHumansImmunological SynapsesLigandsMicroscopy, FluorescenceReceptors, Antigen, T-CellICAM1 protein, humanIntercellular Adhesion Molecule-1LigandsLipid BilayersReceptors, Antigen, T-CellcytotoxicityforceICAM1immunological synapsemobility

Identifiers

PMID41805575
PMCPMC12993941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.